Nationa

Covid-19: The daily dose (June 9, 2021)

PT Jyothi Datt Mumbai | Updated on June 09, 2021

We curate for you all the Covid-19-related developments and stories of the day worth reading

# The Government’s FAQ on blood clots in those taking the AstraZeneca vaccine may provide some relief for those worrying about reports on rare blood clots coming in from European countries. Students and employees are left with just one choice — the AZ vaccine as of now — if they have to go abroad.

# The revised vaccine policy opens up the possibility of fresh price negotiations between vaccine makers and the Centre.

# And the revised vaccine policy — where the Centre procures 75 per cent from vaccine makers — has pushed up the Government’s financial requirement for vaccines to Rs ₹50,000 crore.

# Staying with the revised policy, the Centre’s also outlined the vaccine price at private hospitals.

# Meanwhile, one company making Sputnik in India has just invested in its production facility.

# Did complacency lead to more virus variants in the second wave? Experts believe so.

# And finally, here’s why the Kerala Medical Services Corporation Limited (KMSCL), procurement agency of the State government, informed the Kerala High Court that it had cancelled orders for buying one crore doses of Covid-19 vaccines placed with the two manufacturing companies (Serum and Bharat Biotech).

Published on June 09, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

  1. Comments will be moderated by The Hindu Business Line editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.